![Mutya Harsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mutya Harsch
General Counsel bei
VYNE THERAPEUTICS INC.
Vermögen: 83 134 $ am 31.05.2026
Profil
Mutya Harsch is currently Secretary, Chief Legal Officer & General Counsel at VYNE Therapeutics, Inc. since 2020.
Former positions include Independent Director at Satsuma Pharmaceuticals, Inc. from 2021 to 2023; Secretary, Chief Legal Officer & General Counsel at Menlo Therapeutics, Inc.; Assistant General Counsel at Warner Chilcott, Inc. from 2003 to 2005; Special Counsel-Mergers & Acquisitions at Cooley LLP from 2015 to 2017; Chief Legal Officer & General Counsel at VYNE Pharmaceuticals, Inc. from 2018 to 2020; and Chief Legal Officer & General Counsel at VYNE Pharmaceuticals Ltd. from 2019 to 2020.
Education includes undergraduate and graduate degrees from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VYNE THERAPEUTICS INC 0,37 % | 31.03.2026 | 121 898 ( 0,37 % ) | 83 134 $ | 31.05.2026 |
Aktive Positionen von Mutya Harsch
| Unternehmen | Position | Beginn |
|---|---|---|
| VYNE THERAPEUTICS INC. | General Counsel | 01.03.2020 |
Ehemalige bekannte Positionen von Mutya Harsch
| Unternehmen | Position | Ende |
|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.06.2023 |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | General Counsel | 01.03.2020 |
VYNE Pharmaceuticals, Inc.
 VYNE Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | General Counsel | 01.03.2020 |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.01.2017 |
Warner Chilcott, Inc.
 Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Mutya Harsch
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warner Chilcott, Inc.
Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
VYNE Pharmaceuticals, Inc.
VYNE Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company for migraine and debilitating conditions | Health Technology |
VYNE Therapeutics, Inc.
 VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
